<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Mid Day Module (Obg 1)   2025 03 02</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Mid Day Module (Obg 1)   2025 03 02</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 50 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 60 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 50</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Mid Day Module (Obg 1)   2025 03 02 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 50</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 50 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mm Hg. Investigations reveal 2+ proteinuria on dipstick, an elevated SGOT and SGPT and a platelet count of 80,000/mm 3 . What is the best management?", "options": [{"label": "A", "text": "Oral antihypertensive therapy", "correct": false}, {"label": "B", "text": "Platelet transfusion", "correct": false}, {"label": "C", "text": "Magnesium sulphate therapy and induction of labour", "correct": true}, {"label": "D", "text": "Intravenous immunoglobulin therapy", "correct": false}], "correct_answer": "C. Magnesium sulphate therapy and induction of labour", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-134609.jpg"], "explanation": "<p><strong>Ans. C. Magnesium sulphate therapy and induction of labour</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ Ref: Page no 1852, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1852, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 20-year primi presented at 32 weeks with eclampsia. She was started on MgSO4 (Pritchardâ€™s regime) and she delivered after induction of labor. Maintenance dose of MgSO4 was continued for 24 hours. Prevention of Mg toxicity involves monitoring of the following clinical parameters:", "options": [{"label": "A", "text": "Deep tendon reflexes, urine output, Respiratory rate", "correct": true}, {"label": "B", "text": "Deep tendon reflexes, O2 saturation, consciousness status", "correct": false}, {"label": "C", "text": "O2 saturation, urine output, heart rate", "correct": false}, {"label": "D", "text": "Heart rate, BP, respiratory rate and urine output", "correct": false}], "correct_answer": "A. Deep tendon reflexes, urine output, Respiratory rate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A. Deep tendon reflexes, urine output, Respiratory rate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ The prevention of magnesium toxicity in the management of eclampsia involves careful monitoring of deep tendon reflexes, urine output, and respiratory rate. Deep tendon reflexes help detect early signs of toxicity, urine output indicates renal function and magnesium clearance, and respiratory rate assesses potential respiratory depression from magnesium sulfate.</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 22-year Primigravida presents at 34 weeks to the emergency with a BP of 160/110 mmHg. Her urine albumin is 3 +. She is complaining of headache and blurring of vision. On examination, the fetal heart cannot be auscultated. The uterus is relaxed, and a vaginal examination reveals a soft cervix which is 1 cm dilated and 30% effaced. You administer IV labetalol to lower her BP. What is the best immediate next line of management?", "options": [{"label": "A", "text": "Emergency Cesarean section.", "correct": false}, {"label": "B", "text": "Induction of labor", "correct": false}, {"label": "C", "text": "Prophylactic MgSO4", "correct": true}, {"label": "D", "text": "Urgent Ultrasound to see the fetal status", "correct": false}], "correct_answer": "C. Prophylactic MgSO4", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Prophylactic MgSO4</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ Management of Preeclampsia: Definitive treatment is delivery Mild preeclampsia: Termination at 37 weeks Severe preeclampsia Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if < 34 weeks</li><li>âž¤ Management of Preeclampsia:</li><li>âž¤ Definitive treatment is delivery</li><li>âž¤ Mild preeclampsia: Termination at 37 weeks</li><li>âž¤ Severe preeclampsia Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus</li><li>âž¤ Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus</li><li>âž¤ Admit; Consider prophylactic MgSO4</li><li>âž¤ Start anti-hypertensives</li><li>âž¤ Terminate at 37 weeks or SOS if Persistent severe HTN</li><li>âž¤ Persistent severe HTN</li><li>âž¤ Persistent severe HTN</li><li>âž¤ Eclampsia, HELLP, pulmonary edema, ARF, DIC</li><li>âž¤ Fetal compromise</li><li>âž¤ Abruption</li><li>âž¤ Pre-viable fetus</li><li>âž¤ Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if < 34 weeks</li><li>âž¤ Ref: Page no 732, Williams Obstetrics 25 th edition</li><li>âž¤ Ref: Page no 732, Williams Obstetrics 25 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which is NOT an indication of using this drug in obstetrics?", "options": [{"label": "A", "text": "Neuroprotection in preterm labor", "correct": false}, {"label": "B", "text": "Severe preeclampsia", "correct": false}, {"label": "C", "text": "Tocolysis", "correct": false}, {"label": "D", "text": "Severe IUGR", "correct": true}], "correct_answer": "D. Severe IUGR", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture1.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. D. Severe IUGR</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ MgSO4 is used for the following obstetric indications.</li><li>âž¤ Eclampsia & severe preeclampsia As a tocolytic in preterm labor For neuroprotection in very preterm</li><li>âž¤ Eclampsia & severe preeclampsia</li><li>âž¤ As a tocolytic in preterm labor</li><li>âž¤ For neuroprotection in very preterm</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All are true regarding predictive tests for preeclampsia except?", "options": [{"label": "A", "text": "An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia.", "correct": false}, {"label": "B", "text": "A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.", "correct": false}, {"label": "C", "text": "Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia", "correct": true}, {"label": "D", "text": "Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts", "correct": false}], "correct_answer": "C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-185956.jpg", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-190116.jpg"], "explanation": "<p><strong>Ans. C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ Predictors of preeclampsia:</li><li>âž¤ Predictors of preeclampsia:</li><li>âž¤ Biophysical markers : Raised PI in the uterine Artery (11 â€“ 14 weeks); notching of uterine Artery waveform (mid trimester). Biochemical markers:</li><li>âž¤ Biophysical markers : Raised PI in the uterine Artery (11 â€“ 14 weeks); notching of uterine Artery waveform (mid trimester).</li><li>âž¤ Biophysical markers</li><li>âž¤ Biochemical markers:</li><li>âž¤ Biochemical markers:</li><li>âž¤ S-Flt-1 and s-Eng are Anti-angiogenic factors (Not angiogenic) Roll over test : 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test â€“ 30% of such women will develop pre-eclampsia in the future. This test is not done anymore. Angiotensin II sensitivity test : Rise in BP with Angiotensin II infusion.</li><li>âž¤ S-Flt-1 and s-Eng are Anti-angiogenic factors (Not angiogenic)</li><li>âž¤ Anti-angiogenic factors (Not angiogenic)</li><li>âž¤ Roll over test : 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test â€“ 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</li><li>âž¤ Roll over test</li><li>âž¤ Angiotensin II sensitivity test : Rise in BP with Angiotensin II infusion.</li><li>âž¤ Angiotensin II sensitivity test</li><li>âž¤ Ref: Page no 1818, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1818, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 35-year primigravida is worried about her risk of developing preeclampsia. What intervention would help reduce the risk in her?", "options": [{"label": "A", "text": "Low salt diet", "correct": false}, {"label": "B", "text": "Calcium supplementation started prior to 12 weeks", "correct": false}, {"label": "C", "text": "Aspirin 150 mg/ day prior to 16 weeks", "correct": true}, {"label": "D", "text": "Antioxidants â€“ ascorbic acid and Î±-tocopherol prior to 12 weeks", "correct": false}], "correct_answer": "C. Aspirin 150 mg/ day prior to 16 weeks", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Aspirin 150 mg/ day prior to 16 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</li><li>âž¤ Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</li><li>âž¤ Ref: Page no 1825, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1825, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Anti-hypertensives contra-indicated in pregnancy are all except?", "options": [{"label": "A", "text": "Alpha-methyldopa", "correct": true}, {"label": "B", "text": "Captopril", "correct": false}, {"label": "C", "text": "Enalapril", "correct": false}, {"label": "D", "text": "Losartan", "correct": false}], "correct_answer": "A. Alpha-methyldopa", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A. Alpha-methyldopa</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ The anti-hypertensive drug of choice in pregnancy is labetalol Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy. However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</li><li>âž¤ The anti-hypertensive drug of choice in pregnancy is labetalol</li><li>âž¤ Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy.</li><li>âž¤ However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</li><li>âž¤ Ref: Page no 438, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 438, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All are regimes of MgSO4 for treatment of eclampsia except?", "options": [{"label": "A", "text": "Dhaka regime", "correct": false}, {"label": "B", "text": "Sibai regime", "correct": false}, {"label": "C", "text": "Magpie regime", "correct": true}, {"label": "D", "text": "Zuspan regime", "correct": false}], "correct_answer": "C. Magpie regime", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Magpie regime</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the \"Magpie regime\" is not one of them. Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context.</li><li>âž¤ The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the \"Magpie regime\" is not one of them.</li><li>âž¤ Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context.</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>âž¤ Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 32-year-old primigravida at 39 weeks has a BP recording of 150/100 which when repeated is the same. Her baseline BP during earlier visits was 120/80 mmHg. She does not complain of headache/ blurring of vision or epigastric pain. Abdominal exam reveals a term uterus with cephalic presentation and FHR of 140 bpm. Urine albumin is nil. Which is the most likely diagnosis?", "options": [{"label": "A", "text": "Preeclampsia", "correct": false}, {"label": "B", "text": "Chronic hypertension with superimposed preeclampsia", "correct": false}, {"label": "C", "text": "Eclampsia", "correct": false}, {"label": "D", "text": "Gestational hypertension", "correct": true}], "correct_answer": "D. Gestational hypertension", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D. Gestational hypertension</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Ref: page 1780, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: page 1780, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not a part of HELLP syndrome?", "options": [{"label": "A", "text": "Hemolysis", "correct": false}, {"label": "B", "text": "Elevated liver enzymes", "correct": false}, {"label": "C", "text": "Thrombocytopenia", "correct": false}, {"label": "D", "text": "Retroplacental hemorrhage", "correct": true}], "correct_answer": "D. Retroplacental hemorrhage", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D. Retroplacental hemorrhage</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective</li><li>âž¤ HELLP Syndrome</li><li>âž¤ HELLP Syndrome</li><li>âž¤ It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3 It is a rare complication of pregnancy induced hypertension. It may be associated even with mild hypertension and proteinuria</li><li>âž¤ It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3</li><li>âž¤ It is a rare complication of pregnancy induced hypertension.</li><li>âž¤ It may be associated even with mild hypertension and proteinuria</li><li>âž¤ Ref: Page no 1849, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1849, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A Primigravida presents at 32 weeks with pre-eclampsia. She complains of decreased fetal movements. An umbilical artery Doppler is done which is as shown in the image. What is the next best step in management?", "options": [{"label": "A", "text": "Conservative management with anti-hypertensives", "correct": false}, {"label": "B", "text": "Delivery after 34 weeks of gestation", "correct": false}, {"label": "C", "text": "Immediate delivery", "correct": true}, {"label": "D", "text": "Declare fetal demise", "correct": false}], "correct_answer": "C. Immediate delivery", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture3.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. C. Immediate delivery</strong></p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following are feature(s) of magnesium toxicity in pregnancy? Loss of deep tendon reflex Decreased respiratory rate Decreased urine output Hypertension Increased heart rate", "options": [{"label": "A", "text": "a, b, c", "correct": false}, {"label": "B", "text": "a, d, e", "correct": false}, {"label": "C", "text": "a, b", "correct": true}, {"label": "D", "text": "a, b, c, d", "correct": false}], "correct_answer": "C. a, b", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. a, b</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Features of Magnesium Toxicity:</li><li>âž¤ Features of Magnesium Toxicity:</li><li>âž¤ Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign Decreased respiratory rate (<12 per minute) Chest pain, heart block, pulmonary edema Cardiac arrest O 2 saturation monitoring (PaO2 < 95%) Double vision Slurred speech Nausea-vomiting Muscular weakness</li><li>âž¤ Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</li><li>âž¤ Decreased respiratory rate (<12 per minute)</li><li>âž¤ Chest pain, heart block, pulmonary edema</li><li>âž¤ Cardiac arrest</li><li>âž¤ O 2 saturation monitoring (PaO2 < 95%)</li><li>âž¤ Double vision</li><li>âž¤ Slurred speech</li><li>âž¤ Nausea-vomiting</li><li>âž¤ Muscular weakness</li><li>âž¤ **Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</li><li>âž¤ Ref: Page no 1880, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1880, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 34-year Primigravida presents to the antenatal OPD. Her mother is a diabetic and she is screened for Diabetes at her 8 weeks antenatal visit. What was the most likely screening method used?", "options": [{"label": "A", "text": "FBS & PPBS", "correct": false}, {"label": "B", "text": "HBA1C", "correct": true}, {"label": "C", "text": "Urine routine for sugar", "correct": false}, {"label": "D", "text": "GCT", "correct": false}], "correct_answer": "B. HBA1C", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B. HBA1C</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective (Summary):</li><li>âž¤ Hemoglobin A1C (HBA1C) is the most likely screening method used for diabetes at the 8-week antenatal visit, especially when there is a family history of diabetes. It provides a longer-term view of blood sugar control.</li><li>âž¤ Ref: Page 1108, Williams Obstetrics 25 th edition</li><li>âž¤ Ref: Page 1108, Williams Obstetrics 25 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An infant was born at 36 weeks of pregnancy with a birthweight 4.5 kg as shown in the image. Which of the following conditions is associated with this presentation?", "options": [{"label": "A", "text": "Anemia", "correct": false}, {"label": "B", "text": "Antepartum hemorrhage", "correct": false}, {"label": "C", "text": "Gestational Diabetes mellitus", "correct": true}, {"label": "D", "text": "Thrombocytopenia", "correct": false}], "correct_answer": "C. Gestational Diabetes mellitus", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture13_fMnCKOd.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. C. Gestational Diabetes mellitus</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia. Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</li><li>âž¤ The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia.</li><li>âž¤ Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "For diagnosis of overt gestational diabetes, the fasting blood sugar (FBS] level should be?", "options": [{"label": "A", "text": "â‰¥ 110 mg/dl", "correct": false}, {"label": "B", "text": "â‰¥ 126 mg/dl", "correct": true}, {"label": "C", "text": "â‰¥ 140 mg/dl", "correct": false}, {"label": "D", "text": "â‰¥ 200 mg/dl", "correct": false}], "correct_answer": "B. â‰¥ 126 mg/dl", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-200643.jpg"], "explanation": "<p><strong>Ans. B. â‰¥ 126 mg/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be â‰¥ 126 mg/dl (milligrams per decilitre).</li><li>âž¤ To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be â‰¥ 126 mg/dl (milligrams per decilitre).</li><li>âž¤ It